Summary

In-vitro Inflammatory Bowel Disease Diagnostics Market – Scope of Report
TMR’s report on the global in-vitro inflammatory bowel disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global in-vitro inflammatory bowel disease diagnostics market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro inflammatory bowel disease diagnostics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in-vitro inflammatory bowel disease diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro inflammatory bowel disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro inflammatory bowel disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro inflammatory bowel disease diagnostics market.

The report delves into the competitive landscape of the global in-vitro inflammatory bowel disease diagnostics market. Key players operating in the global in-vitro inflammatory bowel disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro inflammatory bowel disease diagnostics market profiled in this report.

Key Questions Answered in Global in-vitro inflammatory bowel disease diagnostics Market Report
• What is the sales/revenue generated by in-vitro inflammatory bowel disease diagnostics across all regions during the forecast period?
• What are the opportunities in the global in-vitro inflammatory bowel disease diagnostics market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

In-vitro Inflammatory Bowel Disease Diagnostics Market – Research Objectives and Research Approach
The comprehensive report on the global in-vitro inflammatory bowel disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro inflammatory bowel disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro inflammatory bowel disease diagnostics market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global In-Vitro Inflammatory Bowel Disease Diagnostics Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, 2020 - 2034
5. Key Insights
    5.1. Key Product/Brand Analysis
    5.2. Technological Outlook
    5.3. Disease Prevalence and Incidence Rate of Colorectal Cancer in Europe
    5.4. Overview: National Screening Program Scenario
    5.5. Regulatory Scenario in Europe
6. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Product, 2020 - 2034
        6.3.1. Assays/Biomarker
            6.3.1.1. Calprotectin
            6.3.1.2. Lactoferrin
            6.3.1.3. Bile Acids
            6.3.1.4. H. pylori SA
            6.3.1.5. Pancreatic Elastase
            6.3.1.6. Others
        6.3.2. Analyzers
    6.4. Market Attractiveness By Product
7. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Testing Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Testing Type, 2020 - 2034
        7.3.1. Laboratory-based Testing
        7.3.2. Point-of-Care (POC) Testing
        7.3.3. Self-testing Kits
    7.4. Market Attractiveness By Testing Type
8. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By End-user, 2020 - 2034
        8.3.1. Diagnostic Laboratories
        8.3.2. Hospitals
        8.3.3. Others (Homecare Testing & Research Institutes etc.)
    8.4. Market Attractiveness By End-user
9. Global In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecasts, By Region
    9.1. Key Findings
    9.2. Market Value Forecast By Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness By Country/Region
10. North America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Product, 2020 - 2034
        10.2.1. Assays/Biomarker
            10.2.1.1. Calprotectin
            10.2.1.2. Lactoferrin
            10.2.1.3. Bile Acids
            10.2.1.4. H. pylori SA
            10.2.1.5. Pancreatic Elastase
            10.2.1.6. Others
        10.2.2. Analyzers
    10.3. Market Value Forecast By Testing Type, 2020 - 2034
        10.3.1. Laboratory-based Testing
        10.3.2. Point-of-Care (POC) Testing
        10.3.3. Self-testing Kits
    10.4. Market Value Forecast By End-user, 2020 - 2034
        10.4.1. Diagnostic Laboratories
        10.4.2. Hospitals
        10.4.3. Others (Homecare Testing & Research Institutes etc.)
    10.5. Market Value Forecast By Country, 2020 - 2034
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Testing Type
        10.6.3. By End-user
        10.6.4. By Country
11. Europe In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Product, 2020 - 2034
        11.2.1. Assays/Biomarker
            11.2.1.1. Calprotectin
            11.2.1.2. Lactoferrin
            11.2.1.3. Bile Acids
            11.2.1.4. H. pylori SA
            11.2.1.5. Pancreatic Elastase
            11.2.1.6. Others
        11.2.2. Analyzers
    11.3. Market Value Forecast By Testing Type, 2020 - 2034
        11.3.1. Laboratory-based Testing
        11.3.2. Point-of-Care (POC) Testing
        11.3.3. Self-testing Kits
    11.4. Market Value Forecast By End-user, 2020 - 2034
        11.4.1. Diagnostic Laboratories
        11.4.2. Hospitals
        11.4.3. Others (Homecare Testing & Research Institutes etc.)
    11.5. Market Value Forecast By Country, 2020 - 2034
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Testing Type
        11.6.3. By End-user
        11.6.4. By Country
12. Asia Pacific In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Product, 2020 - 2034
        12.2.1. Assays/Biomarker
            12.2.1.1. Calprotectin
            12.2.1.2. Lactoferrin
            12.2.1.3. Bile Acids
            12.2.1.4. H. pylori SA
            12.2.1.5. Pancreatic Elastase
            12.2.1.6. Others
        12.2.2. Analyzers
    12.3. Market Value Forecast By Testing Type, 2020 - 2034
        12.3.1. Laboratory-based Testing
        12.3.2. Point-of-Care (POC) Testing
        12.3.3. Self-testing Kits
    12.4. Market Value Forecast By End-user, 2020 - 2034
        12.4.1. Diagnostic Laboratories
        12.4.2. Hospitals
        12.4.3. Others (Homecare Testing & Research Institutes etc.)
    12.5. Market Value Forecast By Country, 2020 - 2034
        12.5.1. China
        12.5.2. India
        12.5.3. Japan
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Testing Type
        12.6.3. By End-user
        12.6.4. By Country
13. Latin America In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Product, 2020 - 2034
        13.2.1. Assays/Biomarker
            13.2.1.1. Calprotectin
            13.2.1.2. Lactoferrin
            13.2.1.3. Bile Acids
            13.2.1.4. H. pylori SA
            13.2.1.5. Pancreatic Elastase
            13.2.1.6. Others
        13.2.2. Analyzers
    13.3. Market Value Forecast By Testing Type, 2020 - 2034
        13.3.1. Laboratory-based Testing
        13.3.2. Point-of-Care (POC) Testing
        13.3.3. Self-testing Kits
    13.4. Market Value Forecast By End-user, 2020 - 2034
        13.4.1. Diagnostic Laboratories
        13.4.2. Hospitals
        13.4.3. Others (Homecare Testing & Research Institutes etc.)
    13.5. Market Value Forecast By Country, 2020 - 2034
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Testing Type
        13.6.3. By End-user
        13.6.4. By Country
14. Middle East & Africa In-Vitro Inflammatory Bowel Disease Diagnostics Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Product, 2020 - 2034
        14.2.1. Assays/Biomarker
            14.2.1.1. Calprotectin
            14.2.1.2. Lactoferrin
            14.2.1.3. Bile Acids
            14.2.1.4. H. pylori SA
            14.2.1.5. Pancreatic Elastase
            14.2.1.6. Others
        14.2.2. Analyzers
    14.3. Market Value Forecast By Testing Type, 2020 - 2034
        14.3.1. Laboratory-based Testing
        14.3.2. Point-of-Care (POC) Testing
        14.3.3. Self-testing Kits
    14.4. Market Value Forecast By End-user, 2020 - 2034
        14.4.1. Diagnostic Laboratories
        14.4.2. Hospitals
        14.4.3. Others (Homecare Testing & Research Institutes etc.)
    14.5. Market Value Forecast By Country, 2020 - 2034
        14.5.1. GCC
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Testing Type
        14.6.3. By End-user
        14.6.4. By Country
15. Competition Landscape
    15.1. Global Dental Bearings Market : Company Share Analysis (2023)
    15.2. Company Profiles
        15.2.1. F. Hoffmann-La Roche AG
            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.1.2. Product Portfolio
            15.2.1.3. Financial Overview
            15.2.1.4. SWOT Analysis
            15.2.1.5. Strategic Overview
        15.2.2. Thermo Fisher Scientific Inc.
            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2.2. Product Portfolio
            15.2.2.3. Financial Overview
            15.2.2.4. SWOT Analysis
            15.2.2.5. Strategic Overview
        15.2.3. Abbott Laboratories
            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.3.2. Product Portfolio
            15.2.3.3. Financial Overview
            15.2.3.4. SWOT Analysis
            15.2.3.5. Strategic Overview
        15.2.4. Sentinel Diagnostic
            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.4.2. Product Portfolio
            15.2.4.3. Financial Overview
            15.2.4.4. SWOT Analysis
            15.2.4.5. Strategic Overview
        15.2.5. BTNX Inc.
            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.5.2. Product Portfolio
            15.2.5.3. Financial Overview
            15.2.5.4. SWOT Analysis
            15.2.5.5. Strategic Overview
        15.2.6. Immundiagnostik AG
            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.6.2. Product Portfolio
            15.2.6.3. Financial Overview
            15.2.6.4. SWOT Analysis
            15.2.6.5. Strategic Overview
        15.2.7. Quest Diagnostics
            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.7.2. Product Portfolio
            15.2.7.3. Financial Overview
            15.2.7.4. SWOT Analysis
            15.2.7.5. Strategic Overview
        15.2.8. Sysmex Europe SE
            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.8.2. Product Portfolio
            15.2.8.3. Financial Overview
            15.2.8.4. SWOT Analysis
            15.2.8.5. Strategic Overview
        15.2.9. Diasorin S.p.A
            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.9.2. Product Portfolio
            15.2.9.3. Financial Overview
            15.2.9.4. SWOT Analysis
            15.2.9.5. Strategic Overview
        15.2.10. BioSystems S.A.
            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.10.2. Product Portfolio
            15.2.10.3. Financial Overview
            15.2.10.4. SWOT Analysis
            15.2.10.5. Strategic Overview
        15.2.11. QuidelOrtho Corporation
            15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.11.2. Product Portfolio
            15.2.11.3. Financial Overview
            15.2.11.4. SWOT Analysis
            15.2.11.5. Strategic Overview
        15.2.12. Other Prominent Players
            15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.12.2. Product Portfolio
            15.2.12.3. Financial Overview
            15.2.12.4. SWOT Analysis
            15.2.12.5. Strategic Overview